Noribogaine in the treatment of pain and drug addiction
The present invention is directed to methods of treating patients for pain by administering noribogaine. Noribogaine may also be used to treat patients for the symptoms associated with withdrawal from drug dependency. In the latter case, the noribogaine treatment should be supplemented with the administration of an opioid antagonist such as naloxone.
1. A method of treating a patient to alleviate nociceptive pain in the absence of the treatment of drug dependence or drug abuse and in the absence of any concombinant opioid analgesic therapy, comprising: administering systemically to said patient a pharmaceutical composition consisting essentially of an effective amount of noribogaine or its pharmaceutically acceptable salt to said patient effective to reduce or eliminate said nociceptive pain in said patient.
2. The method of claim 1 , wherein said noribogaine or its salt is administered to said patient at a dose of between 0.1 mg and 100 mg per kg of body weight.
3. The method of claim 2 , wherein said noribogaine or its salt is administered at a dose of between 1.0 mg and 30 mg per kg of body weight.
4. The method of claim 1 wherein said noribogaine or its salt is administered transdermally.
5. The method of claim 2 wherein said noribogaine or its salt is administered transdermally.
6. The method of claim 3 wherein said noribogaine or its salt is administered transdermally.
7. The method of claim 1 wherein said noribogaine or its salt is administered parenterally.
8. The method of claim 2 wherein said noribogaine or its salt is administered parenterally.
9. The method of claim 3 wherein said noribogaine or its salt is administered parenterally.
10. The method of claim 1 wherein said noribogaine or its salt is administered orally.
11. The method of claim 2 wherein said noribogaine or is salt is administered orally.
12. The method of claim 3 wherein said noribogaine or its salt is administered orally.